These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 23380959)
1. MicroRNAs in endometrial cancer. Banno K; Yanokura M; Kisu I; Yamagami W; Susumu N; Aoki D Int J Clin Oncol; 2013 Apr; 18(2):186-92. PubMed ID: 23380959 [TBL] [Abstract][Full Text] [Related]
2. [The role of miRNA in endometrial cancer in the context of miRNA 205]. Wilczyński M; Danielska J; Dzieniecka M; Malinowski A Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Boren T; Xiong Y; Hakam A; Wenham R; Apte S; Wei Z; Kamath S; Chen DT; Dressman H; Lancaster JM Gynecol Oncol; 2008 Aug; 110(2):206-15. PubMed ID: 18499237 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis. Kontomanolis EN; Koukourakis MI Microrna; 2015; 4(1):18-25. PubMed ID: 26088599 [TBL] [Abstract][Full Text] [Related]
5. Small non-coding RNA deregulation in endometrial carcinogenesis. Ravo M; Cordella A; Rinaldi A; Bruno G; Alexandrova E; Saggese P; Nassa G; Giurato G; Tarallo R; Marchese G; Rizzo F; Stellato C; Biancardi R; Troisi J; Di Spiezio Sardo A; Zullo F; Weisz A; Guida M Oncotarget; 2015 Mar; 6(7):4677-91. PubMed ID: 25686835 [TBL] [Abstract][Full Text] [Related]
6. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer. Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330 [TBL] [Abstract][Full Text] [Related]
7. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network. Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050 [TBL] [Abstract][Full Text] [Related]
8. The role of miRNAs in endometrial cancer. Vasilatou D; Sioulas VD; Pappa V; Papageorgiou SG; Vlahos NF Epigenomics; 2015; 7(6):951-9. PubMed ID: 26443384 [TBL] [Abstract][Full Text] [Related]
9. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer. Wu X; Han Y; Liu F; Ruan L J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275 [TBL] [Abstract][Full Text] [Related]
11. A step-by-step microRNA guide to cancer development and metastasis. Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501 [TBL] [Abstract][Full Text] [Related]
12. Regulatory network of microRNAs, target genes, transcription factors and host genes in endometrial cancer. Xue LC; Xu ZW; Wang KH; Wang N; Zhang XX; Wang S Asian Pac J Cancer Prev; 2015; 16(2):475-83. PubMed ID: 25684474 [TBL] [Abstract][Full Text] [Related]
13. Verification of microRNA expression in human endometrial adenocarcinoma. Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384 [TBL] [Abstract][Full Text] [Related]
14. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs. Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615 [TBL] [Abstract][Full Text] [Related]
15. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma. Wang P; Zeng Z; Shen X; Tian X; Ye Q DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510 [TBL] [Abstract][Full Text] [Related]
16. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development. Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048 [TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA regulating cell cycle-related tumor suppressor genes in endometrial cancer patients. Witek Ł; Janikowski T; Gabriel I; Bodzek P; Olejek A Hum Cell; 2021 Mar; 34(2):564-569. PubMed ID: 33123872 [TBL] [Abstract][Full Text] [Related]
18. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer. Banno K; Nogami Y; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Susumu N; Aoki D Int J Mol Sci; 2013 Jun; 14(6):12123-37. PubMed ID: 23743825 [TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment. Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862 [TBL] [Abstract][Full Text] [Related]
20. The Dual Role of MicroRNAs in Colorectal Cancer Progression. Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]